Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors. Founded by Omid Farokhzad and Stephen J. Lippard in 2012, Tarveda Therapeutics is backed by investors that include New Enterprise Associates, Versant Ventures, Novo Holdings, Flagship Pioneering, and NanoDimension and is headquartered in Watertown.
FOUNDED:
2012
INDUSTRY:
Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics
FOUNDERS:
Omid Farokhzad, Stephen J. Lippard
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
